000867482 001__ 867482
000867482 005__ 20210130003742.0
000867482 037__ $$aFZJ-2019-06121
000867482 041__ $$aEnglish
000867482 082__ $$a610
000867482 1001_ $$0P:(DE-HGF)0$$aAchillles, Nils$$b0
000867482 245__ $$aComputational fluid dynamics: a suitable assessment tool for demonstrating the antiobstructive effect of drugs in the therapy of allergic rhinitis
000867482 260__ $$bTaylor Francis Group$$c2013
000867482 3367_ $$2DRIVER$$aarticle
000867482 3367_ $$2DataCite$$aOutput Types/Journal article
000867482 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1575389219_12992
000867482 3367_ $$2BibTeX$$aARTICLE
000867482 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000867482 3367_ $$00$$2EndNote$$aJournal Article
000867482 520__ $$aThis systematic review aims first to summarize the previous areas of application of computational fluid dynamics (CFD) and then to demonstrate that CFD is also a suitable instrument for generating three-dimensional images that depict drug effects on nasal mucosa. Special emphasis is placed on the three-dimensional visualization of the antiobstructive effect of nasal steroids and antihistamines in the treatment of allergic rhinitis. In the beginning, CFD technology was only used to demonstrate physiological and pathophysiological airflow conditions in the nose and to aid in preoperative planning and postoperative monitoring of surgical outcome in the field of rhinosurgery. The first studies using CFD examined nasal respiratory physiology, important functions of the nose, such as conditioning and warming of inspired air, and the influence of pathophysiological changes on nasal breathing. Also, postoperative outcome of surgical procedures could be "predicted" using the nasal airflow model. Later studies focused on the three-dimensional visualization of the effect of nasal sprays in healthy subjects and postoperative patients. A completely new approach, however, was the use of CFD in the area of allergic rhinitis and the treatment of its cardinal symptom of nasal obstruction. In two clinical trials, a suitable patient with a positive history of allergic rhinitis was enrolled during a symptom-free period after the pollen season. The patient developed typical allergic rhinitis symptoms after provocation with birch pollen. The 3-D visualization showed that the antiallergic treatment successfully counteracted the effects of nasal allergen provocation on nasal airflow. These observations were attributed to the antiobstructive effect of a nasal steroid (mometasone furoate) and a systemic antihistamine (levocetirizine), respectively. CFD therefore constitutes a non-invasive, precise, reliable and objective examination procedure for generating three-dimensional images that depict the effects of drugs used in the treatment of allergic rhinitis. Abstract available from the publisher.
000867482 536__ $$0G:(DE-HGF)POF3-511$$a511 - Computational Science and Mathematical Methods (POF3-511)$$cPOF3-511$$fPOF III$$x0
000867482 7001_ $$0P:(DE-HGF)0$$aPasch, Norbert$$b1
000867482 7001_ $$0P:(DE-Juel1)165948$$aLintermann, Andreas$$b2$$ufzj
000867482 7001_ $$0P:(DE-HGF)0$$aSchröder, Wolfgang$$b3
000867482 7001_ $$0P:(DE-HGF)0$$aMösges, Ralph$$b4
000867482 773__ $$0PERI:(DE-600)1484331-6$$n1$$p36-42$$tActa oto-laryngologica$$v33$$x0001-6489$$y2013
000867482 8564_ $$uhttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3631816&tool=pmcentrez&rendertype=abstract
000867482 8564_ $$uhttps://juser.fz-juelich.de/record/867482/files/Acta%20otorhinolaryngologica%20Italica%20organo%20ufficiale%20della%20Societ%C3%A0%20italiana%20di%20otorinolaringologia%20e%20chirurgia%20cervico-facciale%20-%202013.pdf$$yRestricted
000867482 8564_ $$uhttps://juser.fz-juelich.de/record/867482/files/Acta%20otorhinolaryngologica%20Italica%20organo%20ufficiale%20della%20Societ%C3%A0%20italiana%20di%20otorinolaringologia%20e%20chirurgia%20cervico-facciale%20-%202013.pdf?subformat=pdfa$$xpdfa$$yRestricted
000867482 909CO $$ooai:juser.fz-juelich.de:867482$$pextern4vita
000867482 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)165948$$aForschungszentrum Jülich$$b2$$kFZJ
000867482 9101_ $$0I:(DE-588b)36225-6$$6P:(DE-HGF)0$$aRWTH Aachen$$b3$$kRWTH
000867482 9131_ $$0G:(DE-HGF)POF3-511$$1G:(DE-HGF)POF3-510$$2G:(DE-HGF)POF3-500$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bKey Technologies$$lSupercomputing & Big Data$$vComputational Science and Mathematical Methods$$x0
000867482 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz
000867482 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bACTA OTO-LARYNGOL : 2017
000867482 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000867482 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000867482 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000867482 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search
000867482 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC
000867482 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List
000867482 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000867482 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000867482 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000867482 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine
000867482 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences
000867482 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000867482 9801_ $$aEXTERN4VITA
000867482 980__ $$ajournal
000867482 980__ $$aUSER
000867482 980__ $$aI:(DE-Juel1)JSC-20090406